Extracorporeal membrane oxygenation exposes infants to the plasticizer, di(2-ethylhexyl)phthalate

Critical Care Medicine

Volumn 25, Issue 4, 1997, Pages 696-703

  Karle, Virginia A ^a,c   Short, Billie L ^a   Martin, Gerard R ^a   Bulas, Dorothy I ^a   Getson, Pamela R ^a   Luban, Naomi L C ^a   O'Brien, Ann M ^a   Rubin, Robert J ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

di(2 ethylhexyl)phthalate; extracorporeal membrane oxygenation; newborn; phthalate; plasticizer; toxicity

Indexed keywords

PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PLASTICIZER;

ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; INFANT; LIVER TOXICITY; LUNG TOXICITY; MALE; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; TOXICITY TESTING;

EID: 0030999899     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199704000-00023     Document Type: Article

References (42)

1. Rubin RJ, Ness PM: What price progress? An update on vinyl plastic blood bags. Transfusion 1989; 29: 358-361
2. Barry YA, Labow RS, Rock G, et al: Cardiotoxic effects of the plasticizer metabolite mono(2-ethylhexyl)phthalate (MEHP) on human myocardium. Blood 1988; 72:1438-1439
3. Jacobson MS, Kevy SV, Grand RJ: Effects of a plasticizer leached from polyvinyl chloride on subhuman primate: A consequence of chronic transfusion therapy. J Lab Clin Med 1977; 89:1066-1078
4. Woodward KN: Phthalate Esters: Toxicity and Metabolism. Vol 1. Boca Raton, FL, CRC Press, 1988, pp 143-160 and 104-121
5. Schulz CO, Rubin RJ, Hutchins GM: Acute lung toxicity and sudden death in rats following the intravenous administration of the plasticizer, di(2-ethylhexyl)phthalate, solubilized with tween surfactants. Toxicol Appl Pharmacol 1975; 33:514-525
6. Rubin RJ, Chang JCF: Effect of the intravenous administration of solubilized plasticizer di(2-ethylhexyl)-phthalate on the lung and on the survival of transfused rats. Toxicol Appl Pharmacol 1978; 45:230
7. Shneider B, Schena J, Truog R, et al: Exposure to di(2-ethylhexyl)phthalate in infants receiving extracorporeal membrane oxygenation. N Engl J Med 1989; 320:1563
8. Beck R, Anderson KD, Pearson GD, et al: Criteria for extracorporeal membrane oxygenation in a population of infants with persistent pulmonary hypertension of the newborn. J Pediatr Surg 1986; 21:297-302
9. Edwards DK, Hilton SW, Merritt TA, et al: Respiratory distress syndrome treated with human surfactant: Radiographic findings. Radiology 1985; 157:329-334
10. Taylor GA, Lotze A, Kapur S, et al: Diffuse pulmonary opacification in infants ' undergoing extracorporeal membrane oxygenation: Clinical and pathologic correlation. Radiology 1986; 161: 347-350
11. Martin G, Short BL: Doppier echocardiogenic evaluation of cardiac performance in infants on prolonged ECMO. Am J Cardiol 1988; 62:929-934
12. Short BL: Clinical management of the neonatal ECMO patient. In: Extracorporeal Life Support. Arensman RM, Cornish JD (Eds). Boston, Blackwell Scientific Publications, 1993, pp 195-206
13. Anderson HL, Otsu T, Chapman RA, et al: Venovenous extracorporeal life support in neonates using a double lumen catheter. Trans Am Soc Artif Intern Organs 1989; 35:650-653
14. Rock G, Secours VE, Franklin CA, et al: The accumulation of mono-2-ethylhexyl phthalate (MEHP) during storage of whole blood and plasma. Transfusion 1978; 18:553-558
15. Myhre BA: Toxicological quandary of the use of bis(2-ethylhexyl)phthalate (DEHP) as a plasticizer for blood bags. Ann Clin Lab Sci 1988; 18:131-140
16. Nassberger L, Arbin A, Ostelius J: Exposure of patients to phthalates from polyvinyl chloride tubes and bags during dialysis. Nephron 1987; 45:286-290
17. Sjoberg P, Bondesson U, Sedin G, et al: Disposition of di and mono(2-ethylhexyl)phthalate in newborn infants subjected to exchange transfusions. Eur J Clin Invest 1975; 15:424-428
18. Avery GB (Ed): Neonatology: Pathophysiology and Management of the Newborn. Third Edition. Philadelphia, JB Lippincott, 1987, pp 557 and 1353
19. Woodward KN: Phthalate Esters: Toxicity and Metabolism. Vol 1. Boca Raton, FL, CRC Press, 1988, pp 47-74
20. Shneider B, Schena J, Troug R, et al: Di(2-ethylhexyl)phthalate exposure during ECMO. Abstr 61. In: Sixth Annual Children's National Medical Center ECMO Symposium, Breckenridge, CO, 1990
21. Rowland TR, Cottrell RC, Phillips JC: Hydrolysis of phthalate esters by the gastrointestinal contents of the rat. Food and Cosmetics Toxicology 1977; 15:17-21
22. Albro PW, Thomas RO: Enzymatic hydrolysis of di(2-ethylhexyl)phthalate by lipases. Biochim Biophys Acta 1973; 360:380-390
23. Mitchell AM, Lhuguenot JC, Bridges JW, et al: Identification of the proximate peroxisome proliferators derived from di(2-ethylhexyl)phthalate. Toxicol Appl Pharmacol 1985; 80:23-32
24. Jaeger RJ, Rubin RJ: Contamination of blood stored in plastic packs. Lancet 1970; ii:151
25. Jaeger RJ, Rubin RJ: Migration of a phthalate ester plasticizer from PVC blood bags into stored human blood and localization in human tissues. N Engl J Med 1972; 287:1114-1118
26. Rubin RJ, Schiffer CA: Fate in humans of the plasticizer di(2-ethylhexyl)-phthalate arising from transfusion of platelets stored in vinyl plastic bags. Transfusion 1976; 16:330-335
27. Hillman LS, Goodman SL, Sherman UR: Identification and measurement of plasticizer in neonatal tissues after umbilical catheters and blood products. N Engl J Med 1975; 292:381-386
28. Lewis LM, Flechtner TW, Kerkay J, et al: Bis(2-ethylhexyl)phthalate concentrations in serum of hemodialysis patients. Clin Chem 1978; 24:741-746
29. Barry YA, Labow RS, Keon WJ, et al: Perioperative exposure to plasticizers in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 97:900-905
30. Woodward KN: Phthalate Esters: Toxicity and Metabolism. Vol 1. Boca Raton, FL, CRC Press, 1988, pp 75-91
31. Shneider B, Maller E, Van Marter L, et al: Cholestasis in infants supported with extracorporeal membrane oxygenation. J Pediatr 1989; 115:462-465
32. Shneider B, Cronin J, Van Martin L, et al: A prospective analysis of cholestasis in infants supported with ECMO. Abstr 36. In: Sixth Annual Children's Hospital National Medical Center ECMO Symposium, Breckenridge, CO, 1990
33. Phang PT, Keough MW: Inhibition of pulmonary surfactant by plasma from normal adults and from patients having cardiopulmonary bypass. J Thorac Cardiovasc Surg 1986; 91:248-251
34. Carilli AD, Ramanamurty MV, Chang VS, et al: Non-cardiogenic pulmonary edema following blood transfusion. Chest 1978; 74:310-312
35. Lotze A, Short BL, Taylor GA: Lung compliance as a measure of lung function in newborns with respiratory failure requiring extracorporeal membrane oxygenation. Crit Care Med 1987; 15: 226-229
36. Taylor GA, Short BL, Kriesmer P: Extracorporeal membrane oxygenation: Radiographic appearance of the neonatal chest. Am J Radiol 1986; 146: 1257-1260
37. Lotze A, Whitsett JA, Kammerman LA, et al: Surfactant protein A concentrations in tracheal aspirate fluid from infants requiring extracorporeal membrane oxygenation. J Pediatr 1990; 116: 435-440
38. Lotze A, Knight GR, Martin GR, et al: Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr 1993; 122:261-268
39. Karr SS, Martin GR, Short BL: Cardiac performance in infants referred for extracorporeal membrane oxygenation. J Pediatr 1991; 118:437-442
40. Agata Y, Satoshi H, Oguchi K, et al: Changes in left ventricular output from fetal to early neonatal life. J Pediatr 1991; 119:441-445
41. Hogman CF, Erikson L, Ericson A, et al: Storage of saline-adenine-glucose-mannitol suspended red cells in a new plastic container; polyvinyl chloride plasticized with butyryl-n-trihexylcitrate. Transfusion 1991; 31:26-29
42. Gulliksson H, Shanwell A, Wikman A, et al: Storage of platelets in a new platelet container. Polyvinyl chloride plasticized with butyryl-n-trihexylcitrate. Vox Sang 1991; 61:165-170